Literature DB >> 8787178

Alterations of GABAB binding caused by acute and chronic lead administration.

J Waśkiewicz1.   

Abstract

The effect of lead on GABAB binding was studied on membranes obtained from acute and chronically lead-treated rats. Acute lead treatment reduced both GABAB affinity (KD) by about 30% and density of receptor (Bmax) by about 15%. On the contrary chronic lead treatment increased receptor capacity by about 20% in spite of decreased receptor affinity by 25%. Both acute and chronic lead treatment shiffted displacement curves toward higher concentration of non-labelled compound (decreased affinity). The results show that lead can affect the GABAB binding in two ways: by reducing affinity of binding and by altering capacity of binding.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8787178

Source DB:  PubMed          Journal:  Acta Neurobiol Exp (Wars)        ISSN: 0065-1400            Impact factor:   1.579


  1 in total

1.  Novel dose-dependent alterations in excitatory GABA during embryonic development associated with lead (Pb) neurotoxicity.

Authors:  Sara E Wirbisky; Gregory J Weber; Jang-Won Lee; Jason R Cannon; Jennifer L Freeman
Journal:  Toxicol Lett       Date:  2014-05-27       Impact factor: 4.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.